Oxidative stress in oncohematologic diseases: an update

References

• Gerschman R, Gilbert DL, Nye SW, Dwyer P, Fenn WO. Oxygen poisoning and x-irradiation: a mechanism in common. Science 119(3097), 623–626 (1954).
   PubMed Web of Science ®Google Scholar
• Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 160(1), 1–40 (2006).
   PubMed Web of Science ®Google Scholar
• Kovacic P, Jacintho JD. Mechanisms of carcinogenesis: focus on oxidative stress and electron transfer. Curr. Med. Chem. 8(7), 773–796 (2001).
   PubMed Web of Science ®Google Scholar
• Ridnour LA, Isenberg JS, Espey MG, Thomas DD, Roberts DD, Wink DA. Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc. Natl Acad. Sci. USA 102(37), 13147–13152 (2005).
   PubMed Web of Science ®Google Scholar
• Valko M, Morris H, Mazúr M, Rapta P, Bilton RF. Oxygen free radical generating mechanisms in the colon: do the semiquinones of vitamin K play a role in the aetiology of colon cancer? Biochim. Biophys. Acta 1527(3), 161–166 (2001).
   PubMed Web of Science ®Google Scholar
• Galli F, Piroddi M, Annetti C, Aisa C, Floridi E, Floridi A. Oxidative stress and reactive oxygen species. Contrib. Nephrol. 149, 240–260 (2005).
   PubMed Web of Science ®Google Scholar
• England K, O’Driscoll C, Cotter TG. Carbonylation of glycolytic proteins is a key response to drug-induced oxidative stress and apoptosis. Cell Death Differ. 11(3), 252–260 (2004).
   PubMed Web of Science ®Google Scholar
• Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39(1), 44–84 (2007).
   PubMed Web of Science ®Google Scholar
• Singh RK, Tripathi AK, Tripathi P, Singh S, Singh R, Ahmad R. Studies on biomarkers for oxidative stress in patients with chronic myeloid leukemia. Hematol. Oncol. Stem Cell Ther. 2(1), 285–288 (2009).
   PubMedGoogle Scholar
• Carr AC, McCall MR, Frei B. Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. Arterioscler. Thromb. Vasc. Biol. 20(7), 1716–1723 (2000).
   PubMed Web of Science ®Google Scholar
• Ng JY, Boelen L, Wong JW. Bioinformatics analysis reveals biophysical and evolutionary insights into the 3-nitrotyrosine post-translational modification in the human proteome. Open Biol. 3(2), 120148 (2013).
   PubMedGoogle Scholar
• Maciag AE, Chakrapani H, Saavedra JE et al. The nitric oxide prodrug JS-K is effective against non-small-cell lung cancer cells in vitro and in vivo: involvement of reactive oxygen species. J. Pharmacol. Exp. Ther. 336(2), 313–320 (2011).
   PubMed Web of Science ®Google Scholar
• Pandey KB, Rizvi SI. Markers of oxidative stress in erythrocytes and plasma during aging in humans. Oxid. Med. Cell. Longev. 3(1), 2–12 (2010).
   PubMed Web of Science ®Google Scholar
• Lee R, Margaritis M, Channon KM, Antoniades C. Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations. Curr. Med. Chem. 19(16), 2504–2520 (2012).
   PubMed Web of Science ®Google Scholar
• Gopalakrishna R, Jaken S. Protein kinase C signaling and oxidative stress. Free Radic. Biol. Med. 28(9), 1349–1361 (2000).
   PubMed Web of Science ®Google Scholar
• De Marco F, Bucaj E, Foppoli C et al. Oxidative stress in HPV-driven viral carcinogenesis: redox proteomics analysis of HPV-16 dysplastic and neoplastic tissues. PLoS ONE 7(3), e34366 (2012).
   PubMedGoogle Scholar
• Dizdaroglu M. Oxidatively induced DNA damage: mechanisms, repair and disease. Cancer Lett. 327(1–2), 26–47 (2012).
   PubMed Web of Science ®Google Scholar
• Ma N, Thanan R, Kobayashi H et al. Nitrative DNA damage and Oct3/4 expression in urinary bladder cancer with Schistosoma haematobium infection. Biochem. Biophys. Res. Commun. 414(2), 344–349 (2011).
   PubMed Web of Science ®Google Scholar
• Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 21(3), 361–370 (2000).
   PubMed Web of Science ®Google Scholar
• Liao D, Corle C, Seagroves TN, Johnson RS. Hypoxia-inducible factor-1α is a key regulator of metastasis in a transgenic model of cancer initiation and progression. Cancer Res. 67(2), 563–572 (2007).
   PubMed Web of Science ®Google Scholar
• Lisanti MP, Martinez-Outschoorn UE, Chiavarina B et al. Understanding the ‘lethal’ drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment. Cancer Biol. Ther. 10(6), 537–542 (2010).
   PubMed Web of Science ®Google Scholar
• Gangemi S, Allegra A, Alonci A et al. Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions. Inflamm. Res. 61(10), 1063–1067 (2012).
   PubMed Web of Science ®Google Scholar
• Poli G, Leonarduzzi G, Biasi F, Chiarpotto E. Oxidative stress and cell signalling. Curr. Med. Chem. 11(9), 1163–1182 (2004).
   PubMed Web of Science ®Google Scholar
• Storz P. Reactive oxygen species in tumor progression. Front. Biosci. 10, 1881–1896 (2005).
   PubMed Web of Science ®Google Scholar
• Gangemi S, Allegra A, Aguennouz M et al. Relationship between advanced oxidation protein products, advanced glycation end products, and S-nitrosylated proteins with biological risk and MDR-1 polymorphisms in patients affected by B-chronic lymphocytic leukemia. Cancer Invest. 30(1), 20–26 (2012).
   PubMed Web of Science ®Google Scholar
• Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81(2), 807–869 (2001).
   PubMed Web of Science ®Google Scholar
• Gupta A, Rosenberger SF, Bowden GT. Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines. Carcinogenesis 20(11), 2063–2073 (1999).
   PubMed Web of Science ®Google Scholar
• Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 30(11), 1191–1212 (2001).
   PubMed Web of Science ®Google Scholar
• Bellavia M, Gioviale MC, Damiano G et al. Dissecting the different biological effects of oncogenic Ras isoforms in cancer cell lines: could stimulation of oxidative stress be the one more weapon of H-Ras? Regulation of oxidative stress and Ras biological effects. Med. Hypotheses 79(6), 731–734 (2012).
   PubMed Web of Science ®Google Scholar
• Meuleman N, Stamatopoulos B, Dejeneffe M, El Housni H, Lagneaux L, Bron D. Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients. Leukemia 22(10), 1882–1890 (2008).
   PubMed Web of Science ®Google Scholar
• Drabko K, Bojarska-Junak A, Kowalczyk J. Activity of superoxide dismutase and glutathione peroxidase and concentrations of malonyldialdehyde, vitamin E, total antioxidant status and extracellular cytokines concentrations in children with acute lymphoblastic leukaemia (ALL). Med. Wieku Rozwoj. 10(3 Pt 1), 861–868 (2006).
   PubMedGoogle Scholar
• Battisti V, Maders LD, Bagatini MD et al. Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukemia patients. Clin. Biochem. 41(7–8), 511–518 (2008).
   PubMed Web of Science ®Google Scholar
• Djurdjevic P, Zelen I, Ristic P et al. Oxidative stress accelerates spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes. J. Buon. 14(2), 281–287 (2009).
   PubMed Web of Science ®Google Scholar
• Ito K, Hirao A, Arai F et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431(7011), 997–1002 (2004).
   PubMed Web of Science ®Google Scholar
• Morabito F, Cristani M, Saija A et al. Lipid peroxidation and protein oxidation in patients affected by Hodgkin’s lymphoma. Mediators Inflamm. 13(5–6), 381–383 (2004).
   PubMed Web of Science ®Google Scholar
• Lanasa MC. Novel insights into the biology of CLL. Hematology Am. Soc. Hematol. Educ. Program 2010, 70–76 (2010).
   PubMedGoogle Scholar
• Al-Gayyar MM, Eissa LA, Rabie AM, El-Gayar AM. Measurements of oxidative stress status and antioxidant activity in chronic leukaemia patients. J. Pharm. Pharmacol. 59(3), 409–417 (2007).
   PubMed Web of Science ®Google Scholar
• Zelen I, Djurdjevic P, Popovic S et al. Antioxidant enzymes activities and plasma levels of oxidative stress markers in B-chronic lymphocytic leukemia patients. J. Buon. 15(2), 330–336 (2010).
   PubMed Web of Science ®Google Scholar
• Schulz A, Toedt G, Zenz T, Stilgenbauer S, Lichter P, Seiffert M. Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2. Haematologica 96(3), 408–416 (2011).
   PubMed Web of Science ®Google Scholar
• Rund D, Azar I, Shperling O. A mutation in the promoter of the multidrug resistance gene (MDR1) in human hematological malignancies may contribute to the pathogenesis of resistant disease. Adv. Exp. Med. Biol. 457, 71–75 (1999).
   PubMed Web of Science ®Google Scholar
• Gollapud S, Gupta S. Anti-P-glycoprotein antibody-induced apoptosis of activated peripheral blood lymphocytes: a possible role of P-glycoprotein in lymphocyte survival. J. Clin. Immunol. 21(6), 420–430 (2001).
   PubMed Web of Science ®Google Scholar
• Güven M, Oztürk B, Sayal A, Ozet A. Lipid peroxidation and antioxidant system in the blood of patients with Hodgkin’s disease. Clin. Biochem. 33(3), 209–212 (2000).
   PubMed Web of Science ®Google Scholar
• Goswami K, Koner BC. Level of sialic acid residues in platelet proteins in diabetes, aging, and Hodgkin’s lymphoma: a potential role of free radicals in desialylation. Biochem. Biophys. Res. Commun. 297(3), 502–505 (2002).
   PubMed Web of Science ®Google Scholar
• Barzilai A, Rotman G, Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair (Amst.) 1(1), 3–25 (2002).
   PubMed Web of Science ®Google Scholar
• Pasanen AK, Kuitunen H, Haapasaari KM et al. Expression and prognostic evaluation of oxidative stress markers in an immunohistochemical study of B-cell derived lymphomas. Leuk. Lymphoma 53(4), 624–631 (2012).
   PubMed Web of Science ®Google Scholar
• Nojima J, Motoki Y, Tsuneoka H et al. ‘Oxidation stress index’ as a possible clinical marker for the evaluation of non-Hodgkin lymphoma. Br. J. Haematol. 155(4), 528–530 (2011).
   PubMed Web of Science ®Google Scholar
• Trotti R, Carratelli M, Barbieri M. Performance and clinical application of a new, fast method for the detection of hydroperoxides in serum. Panminerva Med. 44(1), 37–40 (2002).
   PubMed Web of Science ®Google Scholar
• Kakita H, Hussein MH, Daoud GA et al. Total hydroperoxide and biological antioxidant potentials in a neonatal sepsis model. Pediatr. Res. 60(6), 675–679 (2006).
   PubMed Web of Science ®Google Scholar
• Peroja P, Pasanen AK, Haapasaari KM et al. Oxidative stress and redox state-regulating enzymes have prognostic relevance in diffuse large B-cell lymphoma. Exp. Hematol. Oncol. 1(1), 2 (2012).
   PubMedGoogle Scholar
• Sharma A, Tripathi M, Satyam A, Kumar L. Study of antioxidant levels in patients with multiple myeloma. Leuk. Lymphoma 50(5), 809–815 (2009).
   PubMed Web of Science ®Google Scholar
• Kuku I, Aydogdu I, Bayraktar N, Kaya E, Akyol O, Erkurt MA. Oxidant/antioxidant parameters and their relationship with medical treatment in multiple myeloma. Cell Biochem. Funct. 23(1), 47–50 (2005).
   PubMed Web of Science ®Google Scholar
• Brown CO, Salem K, Wagner BA et al. Interleukin-6 counteracts therapy-induced cellular oxidative stress in multiple myeloma by up-regulating manganese superoxide dismutase. Biochem. J. 444(3), 515–527 (2012).
   PubMed Web of Science ®Google Scholar
• Bodet L, Ménoret E, Descamps G et al. BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma. Br. J. Cancer 103(12), 1808–1814 (2010).
   PubMed Web of Science ®Google Scholar
• Zeng R, Chen Y, Zhao S, Cui GH. Autophagy counteracts apoptosis in human multiple myeloma cells exposed to oridonin in vitro via regulating intracellular ROS and SIRT1. Acta Pharmacol. Sin. 33(1), 91–100 (2012).
   PubMed Web of Science ®Google Scholar
• Yin L, Kosugi M, Kufe D. Inhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPH. Blood 119(3), 810–816 (2012).
   PubMed Web of Science ®Google Scholar
• Azad N, Iyer A, Vallyathan V et al. Role of oxidative/nitrosative stress-mediated Bcl-2 regulation in apoptosis and malignant transformation. Ann. NY Acad. Sci. 1203, 1–6 (2010).
   PubMed Web of Science ®Google Scholar
• Wei W, Li B, Hanes MA, Kakar S, Chen X, Liu L. S-nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis. Sci. Transl. Med. 2(19), 19ra13 (2010).
   PubMed Web of Science ®Google Scholar
• Franke S, Rüster C, Pester J, Hofmann G, Oelzner P, Wolf G. Advanced glycation end products affect growth and function of osteoblasts. Clin. Exp. Rheumatol. 29(4), 650–660 (2011).
   PubMed Web of Science ®Google Scholar
• Musolino C, Alonci A, Allegra A et al. Increase in serum protein carbonyl groups is associated with more advanced stage of disease in multiple myeloma patients. Biomarkers 16(8), 718–719 (2011).
   PubMed Web of Science ®Google Scholar
• Ahmad R, Tripathi AK, Tripathi P, Singh R, Singh S, Singh RK. Studies on lipid peroxidation and non-enzymatic antioxidant status as indices of oxidative stress in patients with chronic myeloid leukaemia. Singapore Med. J. 51(2), 110–115 (2010).
   PubMed Web of Science ®Google Scholar
• Singh RK, Tripathi AK, Tripathi P, Singh S, Singh R, Ahmad R. Studies on biomarkers for oxidative stress in patients with chronic myeloid leukemia. Hematol. Oncol. Stem Cell Ther. 2(1), 285–288 (2009).
   PubMedGoogle Scholar
• Kim JH, Chu SC, Gramlich JL et al. Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species. Blood 105(4), 1717–1723 (2005).
   PubMed Web of Science ®Google Scholar
• Vener C, Novembrino C, Catena FB et al. Oxidative stress is increased in primary and post-polycythemia vera myelofibrosis. Exp. Hematol. 38(11), 1058–1065 (2010).
   PubMed Web of Science ®Google Scholar
• Musolino C, Allegra A, Saija A et al. Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia. Clin. Biochem. 45(16–17), 1439–1443 (2012).
   PubMed Web of Science ®Google Scholar
• Förstermann U. Nitric oxide and oxidative stress in vascular disease. Pflugers Arch. 459(6), 923–939 (2010).
   PubMed Web of Science ®Google Scholar
• Cottler-Fox MH, Lapidot T, Petit I et al. Stem cell mobilization. Hematology Am. Soc. Hematol. Educ. Program 2003, 419–437 (2003).
   Google Scholar
• Aicher A, Heeschen C, Dimmeler S. The role of NOS3 in stem cell mobilization. Trends Mol. Med. 10(9), 421–425 (2004).
   PubMed Web of Science ®Google Scholar
• Lévesque JP, Takamatsu Y, Nilsson SK, Haylock DN, Simmons PJ. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 98(5), 1289–1297 (2001).
   PubMed Web of Science ®Google Scholar
• Barth E, Fischer G, Schneider EM, Moldawer LL, Georgieff M, Weiss M. Peaks of endogenous G-CSF serum concentrations are followed by an increase in respiratory burst activity of granulocytes in patients with septic shock. Cytokine 17(5), 275–284 (2002).
   PubMed Web of Science ®Google Scholar
• Hawkins CL, Pattison DI, Davies MJ. Hypochlorite-induced oxidation of amino acids, peptides and proteins. Amino Acids 25(3–4), 259–274 (2003).
   PubMed Web of Science ®Google Scholar
• Morabito F, Tomaino A, Cristani M et al. ‘In vivo’ time course of plasma myeloperoxidase levels after granulocyte colony-stimulating factor-induced stem cell mobilization. Transfus. Med. 15(5), 425–428 (2005).
   PubMed Web of Science ®Google Scholar
• Yuan X, Cong Y, Hao J et al. Regulation of LIP level and ROS formation through interaction of H-ferritin with G-CSF receptor. J. Mol. Biol. 339(1), 131–144 (2004).
   PubMed Web of Science ®Google Scholar
• Morabito F, Tomaino A, Cristani M et al. Modification of the content of plasma protein carbonyl groups in donors after granulocyte colony stimulating factor-induced stem cell mobilization. Transfus. Apher. Sci. 33(2), 141–146 (2005).
   PubMed Web of Science ®Google Scholar
• Fraser GE. Vegetarian diets: what do we know of their effects on common chronic diseases? Am. J. Clin. Nutr. 89(5), 1607S–1612S (2009).
   PubMed Web of Science ®Google Scholar
• Kazimírová A, Barancoková M, Volkovová K et al. Does a vegetarian diet influence genomic stability? Eur. J. Nutr. 43(1), 32–38 (2004).
   PubMed Web of Science ®Google Scholar
• Spychalowicz A, Wilk G, Sliwa T, Ludew D, Guzik TJ. Novel therapeutic approaches in limiting oxidative stress and inflammation. Curr. Pharm. Biotechnol. 13(13), 2456–2466 (2012).
   PubMed Web of Science ®Google Scholar
• Goodson AG, Cotter MA, Cassidy P et al. Use of oral N-acetylcysteine for protection of melanocytic nevi against UV-induced oxidative stress: towards a novel paradigm for melanoma chemoprevention. Clin. Cancer Res. 15(23), 7434–7440 (2009).
   PubMed Web of Science ®Google Scholar
• Bosco JL, Antonsen S, Sørensen HT, Pedersen L, Lash TL. Metformin and incident breast cancer among diabetic women: a population-based case–control study in Denmark. Cancer Epidemiol. Biomarkers Prev. 20(1), 101–111 (2011).
   PubMed Web of Science ®Google Scholar
• Decensi A, Puntoni M, Goodwin P et al. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev. Res. (Phila). 3(11), 1451–1461 (2010).
   PubMed Web of Science ®Google Scholar
• Goh J, Enns L, Fatemie S et al. Mitochondrial targeted catalase suppresses invasive breast cancer in mice. BMC Cancer 11, 191 (2011).
   PubMed Web of Science ®Google Scholar
• Hewish M, Martin SA, Elliott R, Cunningham D, Lord CJ, Ashworth A. Cytosine-based nucleoside analogs are selectively lethal to DNA mismatch repair-deficient tumour cells by enhancing levels of intracellular oxidative stress. Br. J. Cancer 108(4), 983–992 (2013).
   PubMed Web of Science ®Google Scholar
• Sotgia F, Martinez-Outschoorn UE, Lisanti MP. Mitochondrial oxidative stress drives tumor progression and metastasis: should we use antioxidants as a key component of cancer treatment and prevention? BMC Med. 9, 62 (2011).
   PubMed Web of Science ®Google Scholar
• Ghaffari S. Oxidative stress in the regulation of normal and neoplastic hematopoiesis. Antioxid. Redox Signal. 10(11), 1923–1940 (2008).
   PubMed Web of Science ®Google Scholar
• Tanno T, Matsui W. Development and maintenance of cancer stem cells under chronic inflammation. J. Nippon Med. Sch. 78(3), 138–145 (2011).
   PubMed Web of Science ®Google Scholar
• Allegra A, Coppolino G, Bolignano D et al. Endothelial progenitor cells: pathogenetic role and therapeutic perspectives. J. Nephrol. 22(4), 463–475 (2009).
   PubMed Web of Science ®Google Scholar
• Sosa V, Moliné T, Somoza R, Paciucci R, Kondoh H, LLeonart ME. Oxidative stress and cancer: an overview. Ageing Res. Rev. 12(1), 376–390 (2013).
   PubMed Web of Science ®Google Scholar
• Goel A, Spitz DR, Weiner GJ. Manipulation of cellular redox parameters for improving therapeutic responses in B-cell lymphoma and multiple myeloma. J. Cell. Biochem. 113(2), 419–425 (2012).
   PubMed Web of Science ®Google Scholar
• Kapoor P, Greipp PT, Morice WG, Rajkumar SV, Witzig TE, Greipp PR. Anti-CD20 monoclonal antibody therapy in multiple myeloma. Br. J. Haematol. 141(2), 135–148 (2008).
   PubMed Web of Science ®Google Scholar
• Han SS, Kim K, Hahm ER et al. Arsenic trioxide represses constitutive activation of NF-κB and COX-2 expression in human acute myeloid leukemia, HL-60. J. Cell. Biochem. 94(4), 695–707 (2005).
   PubMed Web of Science ®Google Scholar
• Hussein MA. Trials of arsenic trioxide in multiple myeloma. Cancer Control 10(5), 370–374 (2003).
   PubMedGoogle Scholar
• Diaz Z, Laurenzana A, Mann KK, Bismar TA, Schipper HM, Miller WH Jr. Trolox enhances the anti-lymphoma effects of arsenic trioxide, while protecting against liver toxicity. Leukemia 21(10), 2117–2127 (2007).
   PubMed Web of Science ®Google Scholar
• Bera S, Greiner S, Choudhury A et al. Dexamethasone-induced oxidative stress enhances myeloma cell radiosensitization while sparing normal bone marrow hematopoiesis. Neoplasia 12(12), 980–992 (2010).
   PubMed Web of Science ®Google Scholar
• Allegra A, Penna G, Alonci A, Rizzo V, Russo S, Musolino C. Nanoparticles in oncology: the new theragnostic molecules. Anticancer. Agents Med. Chem. 11(7), 669–686 (2011).
   PubMed Web of Science ®Google Scholar
• Chen Z, Ma L, Liu Y, Chen C. Applications of functionalized fullerenes in tumor theranostics. Theranostics 2(3), 238–250 (2012).
   PubMed Web of Science ®Google Scholar
• Magaye R, Zhao J, Bowman L, Ding M. Genotoxicity and carcinogenicity of cobalt-, nickel- and copper-based nanoparticles. Exp. Ther. Med. 4(4), 551–561 (2012).
   PubMed Web of Science ®Google Scholar
• Ali D, Alarifi S, Kumar S, Ahamed M, Siddiqui MA. Oxidative stress and genotoxic effect of zinc oxide nanoparticles in freshwater snail Lymnaea luteola L. Aquat. Toxicol. 124–125, 83–90 (2012).
   PubMed Web of Science ®Google Scholar
• Ahamed M. Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells. Hum. Exp. Toxicol. 32(2), 186–195 (2013).
   PubMed Web of Science ®Google Scholar